ACB + IPACK Block for Pain Relief
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether adding an IPACK block (a type of pain relief shot) to an adductor canal block (another pain relief shot) reduces pain and the need for opioids after certain knee surgeries. The goal is to determine which combination of pain relief works better for individuals undergoing high tibial osteotomy, distal femoral osteotomy, or tibial tubercle osteotomy. It suits patients scheduled for these surgeries who do not have long-term pain issues or other specific health problems. As a Phase 4 trial, the treatment is already FDA-approved and proven effective, aiming to understand how it benefits more patients.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What is the safety track record for these treatments?
Research has shown that the adductor canal block (ACB) combined with the IPACK block is generally well-tolerated by patients undergoing knee surgery. One study found that this combination provided better pain relief and reduced the need for opioids post-surgery, indicating its safety and effectiveness.
Another study found that using ACB with the IPACK block before surgery helped reduce the risk and severity of long-term pain three months after surgery. Importantly, the adductor canal block itself is recognized as a safe method for pain relief following knee operations.
Overall, evidence suggests these treatments effectively reduce pain with minimal side effects.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about the ACB + IPACK Block treatment for pain relief because it offers a potentially more effective approach to managing postoperative pain, particularly after knee surgeries. Unlike standard treatments that often rely solely on an Adductor Canal Block (ACB), this approach combines ACB with an IPACK block, which targets additional nerves responsible for pain in the knee area. This combination aims to provide more comprehensive pain relief, potentially reducing the need for opioids and their associated side effects. By tackling pain from multiple angles, this method could enhance patient comfort and speed up recovery.
What evidence suggests that this trial's treatments could be effective for post-operative pain relief in osteotomy patients?
Research shows that using an Adductor Canal Block (ACB) with an IPACK block effectively relieves pain after knee surgery. In this trial, some participants will receive the combination of ACB and IPACK block, which studies have found reduces pain both at rest and during knee movement for up to 8 hours post-operation. Patients receiving ACB plus IPACK reported less long-term pain three months after surgery compared to those who received a placebo. Additionally, this approach can lower the need for opioids, which are strong painkillers with potential side effects. The evidence supporting ACB plus IPACK demonstrates a strong record in managing pain after knee surgeries.26789
Who Is on the Research Team?
Laith Jazrawi, MD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for patients aged 18-75 undergoing high tibial, distal femoral, or tibial tubercle osteotomy with low risk of complications (ASA I or II). Excluded are those with chronic pain and opioid use, allergies to oxycodone, additional knee procedures, extreme obesity (BMI over 45), cognitive issues, substance abuse history, severe organ disease, inability to follow instructions or pregnant women.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either an isolated adductor canal block or an adductor canal block combined with IPACK infiltration to manage post-operative pain
Follow-up
Participants are monitored for pain and opioid consumption, with assessments at various post-operative days and a 6-month follow-up
What Are the Treatments Tested in This Trial?
Interventions
- Adductor Canal Block
- IPACK Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor